InVivoMAb Anti-SARS-CoV-2 RBD (JN.1) Neutralizing Antibody (Iv0222)
            Overview
            
                
        
                    | Catalog No. | VK565120 | 
                        | Host species | Human | 
                        | Species reactivity | SARS-CoV-2 (2019-nCoV) | 
                        | Form | Liquid | 
                        | Storage buffer | 0.01M PBS, pH 7.4. | 
                        | Purity | >95% as determined by SDS-PAGE. | 
                        | Clonality | Monoclonal | 
                        | Isotype | IgG1, kappa | 
                        | Applications | ELISA, Neutralization | 
                        | Target | Spike glycoprotein, S glycoprotein, Spike protein S1, Receptor-Binding Domain, RBD, JN.1, SARS-CoV-2 (2019-nCoV) | 
                        | Purification | Protein A/G purified from cell culture supernatant. | 
                        | Endotoxin level | Please contact with the lab for this information. | 
                        | Accession | P0DTC2 | 
                        | Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. | 
                    | Clone ID | Iv0222 | 
                        | Note | For research use only. Not suitable for clinical or therapeutic use. | 
 
            Images
            
                    
                    
                        | -abinscience.jpg?nr=1) Bioactivity
 | Detects SARS-CoV-2 RBD(JN.1) in indirect ELISAs. | 
                    
                        |  SDS-PAGE
 | SDS-PAGE for InVivoMAb Anti-SARS-CoV-2 RBD (JN.1) Neutralizing Antibody (Iv0222). |